X
Record #60267

Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer

Publisher
Elsevier
Original paper date
Jun 21, 2023
Institution
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan · Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80756, Taiwan · Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80756, Taiwan · Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand · Pingtung Hospital, Ministry of Health and Welfare, Pingtung, 900214, Taiwan · Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80756, Taiwan · Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan · Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, 80756, Taiwan · Department of Medical Research, Chi Mei Medical Center, Tainan, 71004, Taiwan · Department of Pathology, Chi Mei Medical Center, Tainan, 71004, Taiwan · National Institute of Cancer Research, National Health Research Institutes, Tainan, 70456, Taiwan · Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand · Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan · Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Toxicology(PHY) Nanotechnology
Notes from Retraction Watch

separate retraction notice published for the correction notice: PMID: 39756365 DOI: 10.1016/j.ijbiomac.2024.138913;

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
9
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~2.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse